scholarly journals A Rasch analysis of the Hospital Anxiety and Depression Scale (HADS) among cancer survivors.

2013 ◽  
Vol 25 (2) ◽  
pp. 379-390 ◽  
Author(s):  
Sylvie D. Lambert ◽  
Julie F. Pallant ◽  
Allison W. Boyes ◽  
Madeleine T. King ◽  
Benjamin Britton ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Rasch Analysis ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Hospital Anxiety

Rasch analysis of the hospital anxiety and depression scale in Parkinson's disease

2008 ◽  
Vol 24 (4) ◽  
pp. 526-532 ◽  
Author(s):  
Maria João Forjaz ◽  
Carmen Rodriguez-Blázquez ◽  
Pablo Martinez-Martin ◽  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Rasch Analysis ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Hospital Anxiety

Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale

2006 ◽  
Vol 15 (9) ◽  
pp. 817-827 ◽  
Author(s):  
A.B. Smith ◽  
E.P. Wright ◽  
R. Rush ◽  
D.P. Stark ◽  
G. Velikova ◽  
...  
Keyword(s):  
Rasch Analysis ◽  
Depression Scale ◽  
Dimensional Structure ◽  
Anxiety And Depression ◽  
Hospital Anxiety

scholarly journals Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease

2011 ◽  
Vol 9 (1) ◽  
pp. 82 ◽  
Author(s):  
Chris J Gibbons ◽  
Roger J Mills ◽  
Everard W Thornton ◽  
John Ealing ◽  
John D Mitchell ◽  
...  
Keyword(s):  
Rasch Analysis ◽  
Depression Scale ◽  
Motor Neurone ◽  
Motor Neurone Disease ◽  
Anxiety And Depression ◽  
Hospital Anxiety

Prevalence and Predictors of Anxiety and Depression Among Cervical Cancer Survivors in Korea

2010 ◽  
Vol 20 (6) ◽  
pp. 1017-1024 ◽  
Author(s):  
Soo Hyun Kim ◽  
Sokbom Kang ◽  
Yong-Man Kim ◽  
Byoung-Gie Kim ◽  
Seok Ju Seong ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cervical Cancer ◽  
Cancer Survivors ◽  
Depression Scale ◽  
Well Being ◽  
Anxiety And Depression ◽  
Life Questionnaire ◽  
Healthy Controls ◽  
Hospital Anxiety

Purpose:With increasing survival rates of women with cervical cancer, quality of life of the survivors becomes a more important issue. However, little is known about the mental health of cervical cancer survivors (CCSs). This study investigated the prevalence of anxiety and depression in CCSs compared with healthy controls and identified factors associated with multidimensional model including sociodemographic, clinical, functioning and well-being, and symptom variables.Methods:The participants included 828 CCSs (mean time since treatment, 6.9 years) enrolled at 6 tertiary hospitals from 1983 to 2004 and 500 control subjects selected randomly from a representative sample of Korean women. Subjects completed the following questionnaires: the Hospital Anxiety and Depression Scale, the European Organization for Research and Treatment of Cancer Quality of Life questionnaire-C30, its Cervical Cancer module, and the McGill Quality of Life Questionnaire.Results:Hospital Anxiety and Depression Scale-defined anxiety in CCSs did not differ from that in healthy controls (39.5% and 32.2%, respectively; P = 0.218). Anxiety was significantly more prevalent in younger CCSs (≤50 years) than in controls (40% vs 26.4%, respectively; P < 0.001). Hospital Anxiety and Depression Scale-defined depression was even lower in CCSs than in controls (34.6% vs 48.0%, respectively; P < 0.001). In multivariate analyses, the Hospital Anxiety and Depression Scale-defined anxiety and depression in CCSs were commonly associated with financial difficulty, poor body image, sexual inactivity, and low existential well-being. Low support and insomnia were uniquely related to anxiety, with older age and decrement role function uniquely related to depression. However, disease-related clinical factors were not related to either anxiety or depression.Conclusions:Cervical cancer survivors showed relatively good mental health compared with healthy controls; however, women who have low functioning and well-being could be at high risk of anxiety or depression or both.

scholarly journals Rasch analysis of the hospital anxiety and depression scale among Chinese cataract patients

PLoS ONE ◽  
2017 ◽  
Vol 12 (9) ◽  
pp. e0185287 ◽  
Author(s):  
Xianchai Lin ◽  
Ziyan Chen ◽  
Ling Jin ◽  
Wuyou Gao ◽  
Bo Qu ◽  
...  
Keyword(s):  
Rasch Analysis ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Cataract Patients

Stehen kognitive Funktionen im Zusammenhang mit Angst, Depression und Posttraumatischer Belastungsstörung bei Brustkrebspatientinnen nach onkologischer Behandlung?

2009 ◽  
Vol 57 (1) ◽  
pp. 33-42 ◽  
Author(s):  
Lena Schirmer ◽  
Anja Mehnert ◽  
Angela Scherwath ◽  
Barbara Schleimer ◽  
Frank Schulz-Kindermann ◽  
...  
Keyword(s):  
Posttraumatic Stress Disorder ◽  
Posttraumatic Stress ◽  
Stress Disorder ◽  
Depression Scale ◽  
Anxiety And Depression ◽  
Hospital Anxiety ◽  
Kognitive Funktionen

Die in mehreren Studien gefundenen kognitiven Störungen bei Tumorpatienten nach Chemotherapie werden zumeist mit der Zytostatikaneurotoxizität assoziiert. In der vorliegenden Arbeit wird der Zusammenhang von Angst, Depression und Posttraumatischer Belastungsstörung mit der kognitiven Leistungsfähigkeit bei Frauen mit Mammakarzinom untersucht. Insgesamt wurden 76 Brustkrebspatientinnen fünf Jahre nach Abschluss der onkologischen Behandlung mit neuropsychologischen Testverfahren sowie mit der Hospital Anxiety and Depression Scale – Deutsche Version (HADS-D) und der Posttraumatic Stress Disorder Checklist – Civilian Version (PCL-C) untersucht: 23 nach Standard- und 24 nach Hochdosistherapie sowie 29 nach Brustoperation und Strahlentherapie als Vergleichsgruppe. Signifikante Zusammenhänge sind vor allem zwischen kognitiven Funktionen und Intrusionssymptomen einer Posttraumatischen Belastungsstörung (PTBS) festzustellen. Bei Patientinnen nach Standardtherapie weisen Intrusionen der PTBS einen moderaten Zusammenhang mit der globalen kognitiven Beeinträchtigung auf. Die Ergebnisse der Studie deuten auf multidimensionale Einfluss- und moderierende Faktoren bei der Entwicklung kognitiver Defizite bei Brustkrebspatientinnen nach onkologischer Therapie hin.

Sign in / Sign up

Export Citation Format

Share Document